Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Koichi Tatsuta"'
Autor:
Mitsuru Yashiro, Masaki Ohya, Toru Mima, Yuri Nakashima, Kazuki Kawakami, Tomohiro Sonou, Koichi Tatsuta, Yukiko Yamano, Shigeo Negi, Takashi Shigematsu
Publikováno v:
Immunity, Inflammation and Disease, Vol 8, Iss 2, Pp 228-235 (2020)
Abstract Introduction We previously reported that fibroblast growth factor 23 (FGF23)‐klotho signaling plays a role in B cell immunity. Despite high serum levels of FGF23, a decline in immunity is frequently observed in patients on hemodialysis (HD
Externí odkaz:
https://doaj.org/article/37e8676dcf67476192ea5211da3efb8c
Autor:
Koichi Tatsuta, Tomohiro Sonou, Toru Mima, Yukiko Yamano, Takashi Shigematsu, Masaki Ohya, Yuri Nakashima, Shigeo Negi, Kazuki Kawakami, Mitsuru Yashiro
Publikováno v:
Immunity, Inflammation and Disease, Vol 8, Iss 2, Pp 228-235 (2020)
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease
Introduction We previously reported that fibroblast growth factor 23 (FGF23)‐klotho signaling plays a role in B cell immunity. Despite high serum levels of FGF23, a decline in immunity is frequently observed in patients on hemodialysis (HD); thus,
Autor:
Yoshiyuki Hanba, Yuri Nakashima, Tomohiro Sonou, Koichi Tatsuta, Daisuke Koreeda, Mitsuru Yashiro, Mari Moribata, Shintaro Yamanaka, Toru Mima, Takashi Shigematsu, Shigeo Negi, Asuka Masumoto, Masaki Ohya
Publikováno v:
Growth Factors. 34:196-202
The FGF23-Klotho signaling axis is known to exert anti-aging effects via calcium-phosphorus metabolism. In mice deficient in FGF23-Klotho signaling, however, the number of splenocytes is reduced. FGF23 is expressed in both bone and spleen, with regul
Autor:
Shigeo Negi, Koichi Tatsuta, Eiichirou Tamaki, Masaki Ohya, Keiko Iseki, Shuto Yamamoto, Satoko Kunimoto, Hiromitsu Kita, Yuri Nakashima, Kouji Okuda, Takaharu Ikeda, Sou Kobayashi, Fukumi Furukawa, Takashi Shigematsu, Toru Mima, Yusuke Shigi
Publikováno v:
Nihon Toseki Igakkai Zasshi. 49:661-668
Autor:
Wataru Yoshimoto, Takurou Yano, Mari Moribata, Asuka Masumoto, Takashi Shigematsu, Shintaro Yamanaka, Koichi Tatsuta, Toshifumi Sakaguchi, Daisuke Koreeda, Yoshiyuki Hanba, Yuri Nakashima, Yusuke Tanaka, Toru Mima, Shuto Yamamoto, Shigeo Negi, Sou Kobayashi, Koji Masumoto, Masaki Ohya
Publikováno v:
Internal Medicine. 54:2207-2211
A 29-year-old woman was diagnosed with Henoch-Schönlein purpura nephritis (HSPN) based on the presence of purpura and histopathological findings showing crescent formation, mesangial proliferation and IgA deposition in the glomerular mesangium. She
[Conservative management and pharmacological intervention for CKD-related mineral and bone disorder]
Publikováno v:
Nihon Jinzo Gakkai shi. 56(8)
Autor:
Tadao Akizawa, Ikuji Hatamura, Koichi Tatsuta, Kazuhiro Shiizaki, Toshifumi Sakaguchi, Sachiko Shimada, Shigeo Negi, Maki Shibata
Publikováno v:
Kidney International. 70:S12-S15
Hyperplasia of the parathyroid gland (PTG) is associated not only with excessive secretion of parathyroid hormone (PTH) but also with changes in the parathyroid cell (PTC) characteristics (i.e. hyperproliferative activity, and low contents of vitamin
Publikováno v:
Journal of Nuclear Science and Technology. 35:477-484
Autor:
Toshihiko Kashii, Takashi Shigematsu, Toshihiro Satou, Toru Mima, Yuri Nakashima, Yuji Kita, Toshifumi Sakaguchi, Shigeo Negi, Masanori Okamoto, Koichi Tatsuta, Ken Kunimoto
Publikováno v:
Internal medicine (Tokyo, Japan). 51(14)
Objective We investigated the present state of, and trends in, hemodialysis therapy in Wakayama, with the aim of identifying present and future problems. Methods We compared the number of patients on maintenance hemodialysis, patients newly commencin
Autor:
Daisuke Koreeda, Takashi Shigematsu, Koichi Tatsuta, Shigeo Negi, Masaki Ohya, Yuri Nakashima, Yoshiyuki Hanba, Toshifumi Sakaguchi, Wataru Yoshimoto, Toru Mima, Shintaro Yamanaka
Publikováno v:
International Journal of Nephrology and Renovascular Disease
Hyperphosphatemia has been shown to be involved not only in the onset and progression of secondary hyperparathyroidism but also in vascular calcification. In addition, it influences the clinical course of patients with chronic kidney disease. Phospha